Testosterone, or any other drugs besides basic stuff like Vitamin D, Creatine, and Collagen
The pill is taken once daily
WADA Prohibition Status Based on WADAs prohibition categories: GLP3 likely falls under Section S0 (Non-Approved Substances) of the WADA Prohibited List, which includes: Any pharmacological substance not approved by governmental regulatory health authorities for human therapeutic use Drugs under preclinical or clinical development Substances without current regulatory approval from any health authority worldwide Implications for competitive athletes: Prohibited at all times (in-competition and out-of-competition) No Therapeutic Use Exemptions available for unapproved substances Use could result in anti-doping rule violations and sanctions Detection methods under development as clinical trials progress Research Classification: GLP3 is available exclusively for use in FDA-approved clinical trials under Investigational New Drug applications
The trial enrolled 338 adults with obesity (BMI 30) or overweight (BMI 27) with at least one weight-related condition
Enhances insulin sensitivity While not the focus here, improved insulin sensitivity indirectly supports metabolism by helping the body use glucose more effectively, reducing fat storage
Along with this, the rising incidence of diabetes and obesity enhances demand for semaglutide, propelling the market forward
